BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36276091)

  • 1. Ferroptosis-related gene signature predicts prognosis in kidney renal papillary cell carcinoma.
    Yin H; Lin M; Liang S; Wei M; Huang C; Qin F; Nong J; Zeng X; Nong C; Qin H
    Front Oncol; 2022; 12():988867. PubMed ID: 36276091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel ferroptosis-related gene prognostic index for prognosis and response to immunotherapy in patients with prostate cancer.
    Wang Y; Fan J; Chen T; Xu L; Liu P; Xiao L; Wu T; Zhou Q; Zheng Q; Liu C; Chan FL; Wu D
    Front Endocrinol (Lausanne); 2022; 13():975623. PubMed ID: 36034466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive model using four ferroptosis-related genes accurately predicts gastric cancer prognosis.
    Wang L; Gong WH
    World J Gastrointest Oncol; 2024 May; 16(5):2018-2037. PubMed ID: 38764813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
    Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
    World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One Ferroptosis-Related Gene-Pair Signature Serves as an Original Prognostic Biomarker in Lung Adenocarcinoma.
    Li L; Wang B
    Front Genet; 2022; 13():841712. PubMed ID: 35368652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Ferroptosis-Related Gene Prognostic Index to Predict Temozolomide Sensitivity and Immune Checkpoint Inhibitor Response for Glioma.
    Cai Y; Liang X; Zhan Z; Zeng Y; Lin J; Xu A; Xue S; Xu W; Chai P; Mao Y; Song Z; Han L; Xiao J; Song Y; Zhang X
    Front Cell Dev Biol; 2021; 9():812422. PubMed ID: 35174170
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction and immunotherapy response in patients with NSCLC.
    Li M; Zhang Y; Fan M; Ren H; Chen M; Shi P
    BMC Med Genomics; 2021 Dec; 14(1):286. PubMed ID: 34861872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and Validation of a 6-Ferroptosis Related Gene Signature for Prognosis and Immune Landscape Prediction in Melanoma.
    Yue Z; Sun J; Shi L
    Front Genet; 2022; 13():887542. PubMed ID: 35692844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma.
    Miao YD; Kou ZY; Wang JT; Mi DH
    World J Clin Cases; 2021 Oct; 9(29):8671-8693. PubMed ID: 34734046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a ferroptosis-related gene signature (FRGS) for predicting clinical outcome in lung adenocarcinoma.
    Wang S; Wu C; Ma D; Hu Q
    PeerJ; 2021; 9():e11233. PubMed ID: 33954048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma.
    Sun Z; Jing C; Xiao C; Li T; Wang Y
    Aging (Albany NY); 2020 Nov; 12(21):22078-22094. PubMed ID: 33177247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer.
    Liang Y; Ye F; Xu C; Zou L; Hu Y; Hu J; Jiang H
    BMC Cancer; 2021 Aug; 21(1):943. PubMed ID: 34418989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients.
    Li H; Zhang X; Yi C; He Y; Chen X; Zhao W; Yu D
    BMC Cancer; 2021 Jul; 21(1):835. PubMed ID: 34284753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and analysis of a novel ferroptosis-related gene signature predicting prognosis in lung adenocarcinoma.
    Zhou J; Wang X; Li Z; Jiang R
    FEBS Open Bio; 2021 Nov; 11(11):3005-3018. PubMed ID: 34499810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential biomarkers for predicting the overall survival outcome of kidney renal papillary cell carcinoma: an analysis of ferroptosis-related LNCRNAs.
    Wu Z; Huang X; Cai M; Huang P
    BMC Urol; 2022 Sep; 22(1):152. PubMed ID: 36104680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of A Novel Ferroptosis-related Prognostic Risk Signature for Survival Prediction in Clear Cell Renal Cell Carcinoma Patients.
    Tang F; Zhang J; Zhu L; Lai Y; Li Z; Lu Z; Tang Z; Mai Y; Huang R; He Z
    Urol J; 2022 May; 19(4):289-299. PubMed ID: 35598038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and Validation of a Prognostic Signature for Prostate Cancer Based on Ferroptosis-Related Genes.
    Liu H; Gao L; Xie T; Li J; Zhai TS; Xu Y
    Front Oncol; 2021; 11():623313. PubMed ID: 34336641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer.
    Yang L; Li C; Qin Y; Zhang G; Zhao B; Wang Z; Huang Y; Yang Y
    Front Oncol; 2021; 11():686044. PubMed ID: 34422642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma.
    Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J
    Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.